MARIANA SMITH: Open Payments
NPI 1700960556 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 8 payments from 5 companies in 2025. Trend: 2023 $736 · 2024 $986 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 1 | $102 |
| Lilly USA, LLC | 4 | $66 |
| Gilead Sciences, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: NEXLETOL, MOUNJARO, Yeztugo, Ozempic, Kerendia.
Industry payments across TX — which companies pay providers there.
